INRatio and INRatio2 PT/INR Monitor System by Alere: Recall - Potentially Inaccurate INR Results

Alere is working with the FDA to determine the most appropriate timing for product discontinuation and will provide guidance on transitioning patients to an alternate solution.

Source: FDA MedWatch Safety Alert - July 12, 2016 Category: American Health Source Type: alerts